IRMD: IRADIMED CORPORATION - Summary | Jitta

IRADIMED CORPORATION

NASDAQ:IRMD

Price
$93.60
Loss Chance
42.4%
7.06JITTA SCORE
166.59%Over Jitta Line
Jitta Ranking
88 / 715
978 / 4,222
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (75)
Recent Business Performance (67)
Financial Strength (77)
Return to Shareholders (69)
Competitive Advantage (80)
Jitta Signs
Revenue and EarningConsistent High Growth in the past 5 years
Operating MarginExpansion
Debt LevelLow Long Term Debt
SG&A to SalesDecreasing
Cash Conversion CycleMore than 120 days
Key Stats
Jitta Score
Jitta Line
7.06
166.59%
3.05
162.56%
Health Care Equipment
5.75
1.27%
7.38
27.09%
7.50
1.53%
COMPANY DESCRIPTION
IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible intravenous infusion pump systems and MRI compatible patient vital signs monitoring systems and related accessories. The company offers MRidium 3870 and 3860+ MRI Compatible IV Infusion Pump System with associated disposable IV tubing sets; 3880 MRI compatible patient vital signs monitoring system; and 3600 FMD1 with remote alarm logging unit ferromagnetic detection device. It also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. The company serves hospitals, acute care facilities, and outpatient imaging centers. It sells its products through direct field sales representatives, regional sales directors, clinical application specialists, and independent distributors in the United States and internationally. The company was incorporated in 1992 and is headquartered in Orlando, Florida.